Public summary documents – November 2021 PBAC meeting (first time rejections and deferrals)

18 March 2022 - The Public Summary Documents (first time rejections and deferrals) from the November 2021 PBAC meeting are now ...

Read more →

Public summary documents – November 2021 PBAC meeting

4 March 2022 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the November 2021 PBAC ...

Read more →

How are child specific utility instruments used in decision making in Australia? A review of Pharmaceutical Benefits Advisory Committee public summary documents.

28 January 2022 - Measuring and valuing health-related quality of life in children can be challenging but is an important component ...

Read more →

PBAC Public Summary Documents – September 2021 meeting (first time rejections and deferrals)

14 January 2022 - The Public Summary Documents (first time rejections and deferrals) from the September 2021 PBAC meeting are now ...

Read more →

Public Summary Documents – September 2021 PBAC meeting

24 December 2021 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the September 2021 PBAC ...

Read more →

PBS expenditure and prescriptions report 2020-21

24 December 2021 - The PBS Expenditure and Prescriptions Report 1 July 2020 to 30 June 2021 is now available. ...

Read more →

Report on the collection of under co-payment data 2020-21

24 December 2021 - The report on the collection of under co-payment data 2020-21 is now available. ...

Read more →

Preparing for health care’s new frontier: Committee releases major report on reforming the process for new medicines and health technology

25 November 2021 - A new parliamentary report ‘The New Frontier: Delivering better health for all Australians’ is recommending significant ...

Read more →

Semaglutide (Wegovy) stakeholder meeting outcome statement

24 November 2021 - The outcome statement for the semaglutide stakeholder meeting held on 26 August 2021 is now available. ...

Read more →

Public Summary Documents (first time rejections and deferrals) – July 2021 PBAC meeting

12 November 2021 - The Public Summary Documents (first time rejections and deferrals) from the July 2021 PBAC meeting are now ...

Read more →

Drug Utilisation Sub-Committee outcome statement

5 November 2021 - The Outcome Statement from the October 2021 Drug Utilisation SubCommittee meeting is now available. ...

Read more →

PBAC Public Summary Documents (first time decisions not to recommend, deferrals and other matters) – May 2021 meeting

10 September 2021 - The Public Summary Documents (first time decisions not to recommend, deferrals and other matters) from the May ...

Read more →

Public Summary Documents – May 2021 PBAC meeting

27 August 2021 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the May 2021 PBAC ...

Read more →

PBAC Public Summary Documents (first time rejections and deferrals) – March 2021 meeting

16 July 2021 - The Public Summary Documents (first time rejections and deferrals) from the March 2021 PBAC meeting are now ...

Read more →

PBAC Public Summary Document for risdiplam – March 2021 meeting

5 July 2021 - The Public Summary Document for risdiplam from the March 2021 PBAC meeting is now available. ...

Read more →